Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

151 to 175 of 176 results

Suneva Medical acquires product portfolio from Spear Pharma

24-05-2012

Privately-held US aesthetics company Suneva Medical has acquired an aesthetic product portfolio from…

DermatologicalsGenericsMergers & AcquisitionsPharmaceuticalRefissaSpear PharmaceuticalsSuneva MedicalTretinoin

Novartis to buy US generic derma company Fougera for over $1.5 billion

03-05-2012

Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNovartisPharmaceuticalSandoz

Global generic drug markets will grow to $221 billion by 2016; Espicom

29-04-2012

The economic recession has been a double-edged sword for the international generic drugs business. Driven…

GenericsGlobalMarkets & MarketingMergers & AcquisitionsPricing

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis

26-04-2012

US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Watson Pharma confirms buy of generic group Actavis for 4.25 billion euros

26-04-2012

As has been widely rumoured over this week, Watson Pharmaceuticals (NYSE: WPI) has confirmed a definitive…

ActavisGenericsMergers & AcquisitionsWatson Pharmaceuticals

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland

19-04-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Sigma-Aldrich acquires Research Organics; opens new facility in China

16-04-2012

USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based,…

Asia-PacificGenericsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResearch OrganicsSigma-Aldrich

Kyowa Hakko sets up biosimilars joint venture with Fujifilm

29-03-2012

Japanese digital camera and medical equipment conglomerate Fujifilm and drugmaker Kyowa Hakko Kirin have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyFujifilm Kyowa Kirin BiologicsGenericsHumiraKyowa Hakko KirinMergers & AcquisitionsResearch

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis

29-03-2012

There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

Actavis reportedly to be acquired by Watson; debuts generic Zomig

22-03-2012

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals…

ActavisAstraZenecaEuropeGenericsMarkets & MarketingMergers & AcquisitionsNeurologicalPatentsWatson PharmaceuticalsZolmitriptanZomig

Flamel Tech acquires US firm Eclat Pharma; reports loss

19-03-2012

Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Mylan gets OK for generic Crestor in Canada; Rottapharm deal looks dead

18-03-2012

The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health…

AstraZenecaCardio-vascularCrestorEuropeGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaPharmaceuticalRegulationRottapharm

Valeant goes shopping again, buying branded generics from Gerot Lannach

14-03-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

AspirinGenericsGerot LannachMergers & AcquisitionsValeant Pharmaceuticals

Pfizer and Hisun flesh-out plans for generics JV in China

19-02-2012

Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Merck & Co sets up marketing JV in Brazil

16-02-2012

Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian…

CristaliaEurofarmaGenericsMarkets & MarketingMerck & CoMergers & AcquisitionsPharmaceuticalSouth AmericaSupera Farma

Shanghai Pharma aims to take control of Kony Pharma

07-02-2012

In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding…

Asia-PacificGenericsKony PharmaMergers & AcquisitionsShanghai Pharmaceutical Group

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

Watson buys Strides Arcolab unit for A$375 million; 2011 results

24-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

India’s Dishman buys French company

17-01-2012

Indian drugmaker Dishman Pharmaceuticals and Chemicals says that its Swiss unit has acquired a contract…

CréapharmGenericsMergers & Acquisitions

2011 a bumper year for Pharma, Biotech and Generics M&A

11-01-2012

Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

151 to 175 of 176 results

Back to top